Andersen Mads J, Borlaug Barry A
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA; Department of Cardiology, Aarhus University Hospital, Brendstrupgårdsvej 100, DK-8200 Aarhus N, Aarhus, Denmark.
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Heart Fail Clin. 2014 Jul;10(3):435-44. doi: 10.1016/j.hfc.2014.03.001.
Recent hemodynamic studies have advanced our understanding of heart failure with preserved ejection fraction (HFpEF). Despite improved pathophysiologic insight, clinical trials have failed to identify an effective treatment for HFpEF. Invasive hemodynamic assessment can diagnose or exclude HFpEF, making it invaluable in understanding the basis of the disease. This article reviews the hemodynamic mechanisms underlying HFpEF and how they manifest clinically, discusses invasive hemodynamic assessment as a diagnostic tool, and explores how invasive hemodynamic profiling may allow understanding of pathophysiological differences and inform the design and entry criteria for future trials.
近期的血流动力学研究增进了我们对射血分数保留的心力衰竭(HFpEF)的理解。尽管对病理生理学有了更深入的认识,但临床试验仍未能找到针对HFpEF的有效治疗方法。有创血流动力学评估可用于诊断或排除HFpEF,这对于理解该疾病的发病基础具有重要价值。本文回顾了HFpEF背后的血流动力学机制及其临床表型,讨论了有创血流动力学评估作为一种诊断工具的作用,并探讨了有创血流动力学分析如何有助于理解病理生理差异,以及为未来试验的设计和入选标准提供依据。